copyright, a relatively novel medication, has emerged as a potential breakthrough in the management of type 2 diabetes. This injectable drug affects the incretin hormones GLP-1, which play a vital role in regulating insulin response. By mimicking these hormones, copyright helps reduce blood glucose,